Joy Minju, Chakraborty Kajal
Marine Biotechnology Division, Central Marine Fisheries Research Institute, Ernakulam North, P.B. No. 1603, Cochin, India.
Marine Biotechnology Division, Central Marine Fisheries Research Institute, Ernakulam North, P.B. No. 1603, Cochin, India.
Steroids. 2018 Jul;135:1-8. doi: 10.1016/j.steroids.2018.04.007. Epub 2018 Apr 20.
The estuarine Corbiculid bivalve black clam, Villorita cyprinoides collected from the Southwestern coastline regions of Arabian Sea are significant resources of nutritional and bioactive pluralities. The purification of ethyl acetate:methanol (EtOAc:MeOH) extract of V. cyprinoides characterized a previously undisclosed specialized abeo-pregnane-type sterol derivative 19 (10 → 5) abeo-20-methyl-pregn-10-en-3β-yl-hex-(3'E)-enoate (1) along with two cholestenols (22E),(24E)-24,24-dihomocholesta-5,22,24-trien-3β-ol (2) and (22E)-24-homocholesta-5,22-dien-(3β,24β)-diol (3). These compounds were characterized by comprehensive spectroscopic investigations. The anti-inflammatory (anti-cyclooxygenase-1, 2/5-lipoxidase) activities of 1 were considerably higher (IC < 1.10 mg/mL) than 2-3 (IC > 1.10 mg/mL). These studied compounds registered greater selectivity indices (∼1.03) against cyclooxygenase-2 than cyclooxygenase-1. The antioxidant property of abeo-pregnane-type sterol as determined by in vitro 2,2'-azino-bis-(3-ethyl-benzthiazoline-6-sulfonic acid) quenching potential was significantly greater (IC 0.94 mg/mL) than those of substituted dihomocholesta-trien-ol (2) and homocholesta-dien-diol (3) (IC > 1.00 mg/mL). Structure-activity relationship studies demonstrated that bioactive potentials of the titled compounds were linearly related to their electronic factors along with optimum hydrophobic factors. In addition, molecular docking studies were performed in the active sites of COX-2 and their binding energies and docking scores were well correlated with in vitro anti-COX-2 potentials.
从阿拉伯海西南海岸线地区采集的河口蚬科双壳贝类黑蚬(Villorita cyprinoides)是营养和生物活性物质的重要来源。对黑蚬乙酸乙酯:甲醇(EtOAc:MeOH)提取物的纯化鉴定出一种先前未公开的特殊去甲孕甾烷型甾醇衍生物19(10→5)去甲-20-甲基-孕-10-烯-3β-基-己-(3'E)-烯酸酯(1),以及两种胆甾烯醇,即(22E),(24E)-24,24-二高胆甾-5,22,24-三烯-3β-醇(2)和(22E)-24-高胆甾-5,22-二烯-(3β,24β)-二醇(3)。这些化合物通过全面的光谱研究进行了表征。化合物1的抗炎(抗环氧化酶-1、2/5-脂氧化酶)活性(IC<1.10mg/mL)明显高于化合物2-3(IC>1.10mg/mL)。这些研究的化合物对环氧化酶-2的选择性指数(约1.03)高于环氧化酶-1。通过体外2,2'-联氮-双-(3-乙基苯并噻唑啉-6-磺酸)猝灭电位测定,去甲孕甾烷型甾醇的抗氧化性能(IC0.94mg/mL)明显高于取代二高胆甾三烯醇(2)和高胆甾二烯二醇(3)(IC>1.00mg/mL)。构效关系研究表明,标题化合物的生物活性潜力与其电子因素以及最佳疏水因素呈线性相关。此外,在环氧化酶-2的活性位点进行了分子对接研究,其结合能和对接分数与体外抗环氧化酶-2潜力具有良好的相关性。